Cited by 548Tuberculosis Research and EpidemiologyImmune responses and vaccinationsInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Metformin as adjunct antituberculosis therapy

Singhal, Amit, Jie, Liu, Kumar, Pavanish, Hong, Gan Suay, Leow, Melvin Khee-Shing, Paleja, Bhairav, Tsenova, Liana, Kurepina, Natalia, Chen, Jinmiao, Zolezzi, Francesca, Kreiswirth, Barry, Poidinger, Michael, Chee, Cynthia, Kaplan, Gilla, Wang, Yee Tang, De Libero, Gennaro·2014·Science Translational Medicine

DOI 10.1126/scitranslmed.3009885

Open this paper in CoChat — free account

Abstract

The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate-activated protein kinase)-dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3009885

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659

Show all 49 references

Sorted by citations

Items 201–300 of 548

Non-antibiotic adjunctive therapy: A promising approach to fight tuberculosis
Khameneh, B., Iranshahy, M., Vahdati-Mashhadian, N., Sahebkar, A., & Bazzaz, B. S. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104289 · Cited by 30
Tolerating the Unwelcome Guest; How the Host Withstands Persistent Mycobacterium tuberculosis
Olive, A. J., & Sassetti, C. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02094 · Cited by 27
FX11 limits Mycobacterium tuberculosis growth and potentiates bactericidal activity of isoniazid through host-directed activity
Gopinath, K., Kaiser, P., Abed, U. A., Weiner, J. M., Moura‐Alves, P., Brinkmann, V., & Kaufmann, S. H. E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.041954 · Cited by 25
Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages
Anwar, A., Soomaroo, A., Anwar, A., Siddiqui, R., & Khan, N. A. (2020) · Experimental Parasitology · doi:10.1016/j.exppara.2020.107915 · Cited by 27
Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV
Calvet‐Mirabent, M., Sánchez‐Cerrillo, I., Martin-Cofreces, N. B., Martínez‐Fleta, P., de la Fuente, H., Tsukalov, I., Delgado‐Arévalo, C., Calzada, M. J., Santos, I. D. L., Sanz, J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104090 · Cited by 27
Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection
Park, H.-E., Lee, W., Choi, S., Jung, M., Shin, M., & Shin, S. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931876 · Cited by 29
Recent advances for identification of new scaffolds and drug targets for Mycobacterium tuberculosis
Dhiman, R., & Singh, R. (2018) · IUBMB Life · doi:10.1002/iub.1863 · Cited by 27
How mycobacteria take advantage of the weakness in human immune system in the modern world
Chao, W.-C., Yen, C., Wu, C., & Shieh, C.-C. K. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.10.008 · Cited by 25
Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection
Bhatt, K., Bhagavathula, M., Verma, S., Timmins, G. S., Deretic, V. P., Ellner, J. J., & Salgame, P. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049018 · Cited by 26
Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go
Pellegrini, J. M., Tateosian, N. L., Morelli, M. P., & García, V. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.820095 · Cited by 26
Diabetes and Tuberculosis
Restrepo, B. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-97367-8_1 · Cited by 26
Diabetes-related tuberculosis in the Middle East: an urgent need for regional research
Alkabab, Y., Al-Abdely, H. M., & Heysell, S. K. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.09.010 · Cited by 27
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery
O’Connor, G., Gleeson, L. E., Fagan-Murphy, A., Cryan, S., O’Sullivan, M. P., & Keane, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.024 · Cited by 27
Diabetes and Tuberculosis
Restrepo, B. I. (2017) · ASM Press eBooks · doi:10.1128/9781555819866.ch35 · Cited by 29
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
Bahlool, A. Z., Grant, C., Cryan, S., Keane, J., & O’Sullivan, M. P. (2022) · Current Research in Immunology · doi:10.1016/j.crimmu.2022.03.003 · Cited by 28
Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
Zhao, L., Fan, K., Sun, X., Li, W., Qin, F., Shi, L., Gao, F., & Zheng, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305325 · Cited by 26
Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity
Khan, A., Hunter, R. L., & Jagannath, C. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.09.019 · Cited by 25
Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity
Lim, J., Koh, V. H. Q., Cho, S. L. S., Periaswamy, B., Choi, D. P. S., Vacca, M., de Sessions, P. F., Kudela, P., Lubitz, W., Pastorin, G., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02737 · Cited by 25
Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis
Swaminathan, S., Sundaramurthi, J. C., Palaniappan, A. N., & Narayanan, S. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.08.002 · Cited by 24
Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways
Benedetti, F., Sorrenti, V., Buriani, A., Fortinguerra, S., Scapagnini, G., & Zella, D. (2020) · Viruses · doi:10.3390/v12121458 · Cited by 26
The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00343-x · Cited by 25
Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India
Gupte, A., Mave, V., Meshram, S., Lokhande, R., Kadam, D., Dharmshale, S., Bharadwaj, R. S., Kagal, A., Pradhan, N., Deshmukh, S., et al. (2018) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0026 · Cited by 25
Nicotinamide Limits Replication of Mycobacterium tuberculosis and Bacille Calmette-Guérin Within Macrophages
Simmons, J. D., Peterson, G. J., Campo, M., Lohmiller, J., Skerrett, S. J., Tunaru, S., Offermanns, S., Sherman, D. R., & Hawn, T. R. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz541 · Cited by 24
Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis
Haugen, J. D., Ackart, D. F., Todd, A., DiLisio, J. E., Hoffman, S., Tanner, S., Kiran, D., Murray, M. B., Chicco, A. J., Obregón‐Henao, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73212-y · Cited by 24
Repurposing nonantibiotic drugs as antibacterials
Thakare, R., Kaul, G., Shukla, M., Kesharwani, P., Srinivas, N., Dasgupta, A., & Chopra, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00005-9 · Cited by 14
Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil
Moreira, J., Castro, R., Lamas, C. D. C., Ribeiro, S. R., Grinsztejn, B. G. J., & Veloso, V. G. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.12.014 · Cited by 24
Role of Tumor Necrosis Factor in Tuberculosis
Дмитриевич, К. Ф., Lopatnikova, J., Alshevskaya, A., & Sennikov, S. V. (2025) · Biomolecules · doi:10.3390/biom15050709 · Cited by 28
Immunometabolism at the crossroads of infection: mechanistic and systems-level perspectives from host and pathogen
Malla, S., Shahreen, N., & Saha, R. (2025) · Immunometabolism · doi:10.1097/in9.0000000000000069 · Cited by 30
The Troika Host–Pathogen–Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes
Bastos, H. N., Osório, N. S., Gagneux, S., Comas, I., & Saraiva, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01948 · Cited by 23
Potentials of Host-Directed Therapies in Tuberculosis Management
Dara, Y., Volcani, D., Shah, K., Shin, K., & Venketaraman, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081166 · Cited by 23
Human monocyte-derived macrophage responses to M. tuberculosis differ by the host's tuberculosis, diabetes or obesity status, and are enhanced by rapamycin
Restrepo, B. I., Khan, A., Singh, V. K., de-Leon, E., Aguillón-Durán, G. P., Ledezma-Campos, E., Canaday, D. H., & Jagannath, C. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102047 · Cited by 23
Mitochondrial reactive oxygen species: double agents in Mycobacterium tuberculosis infection
Ellzey, L. M., Patrick, K. L., & Watson, R. O. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102366 · Cited by 22
Infections
Chakraborty, S., Bhattacharyya, R., & Banerjee, D. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.11.004 · Cited by 22
Formulation of host-targeted therapeutics against bacterial infections
Varma, D. M., Zahid, M. S. H., Bachelder, E. M., & Ainslie, K. M. (2020) · Translational research · doi:10.1016/j.trsl.2020.03.009 · Cited by 22
Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis
Ugarte‐Gil, C., Carrillo-Larco, R. M., & Kirwan, D. E. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.018 · Cited by 21
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria
Matteucci, K. C., Correa, A. A. D. S., & Costa, D. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.905278 · Cited by 23
Metformin in tuberculosis: beyond control of hyperglycemia
Oglesby, W., Kara, A. M., Granados, H., & Cervantes, J. (2019) · Infection · doi:10.1007/s15010-019-01322-5 · Cited by 21
Revisiting hypoxia therapies for tuberculosis
Oehlers, S. H. (2019) · Clinical Science · doi:10.1042/cs20190415 · Cited by 20
Host-Directed Therapeutic for the treatment of Mycobacterium tuberculosis
Mahajan, P., Gor, H., Jadhav, S., Joshi, M., & Nema, V. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128253 · Cited by 20
The integration of omics: A promising approach to personalized tuberculosis treatment
GUHA, P. S., Dutta, S., Murti, K., Charan, J. K., Pandey, K., Ravichandiran, V., & Dhingra, S. (2024) · Medicine in Omics · doi:10.1016/j.meomic.2024.100033 · Cited by 20
The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds
Mi, J., Wu, X., & Liang, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1380848 · Cited by 20
Biguanides enhance antifungal activity against Candida glabrata
Xu, S., Feliu, M., Lord, A. K., Lukason, D. P., Negoro, P. E., Khan, N. S., Dagher, Z., Feldman, M. B., Reedy, J. L., Steiger, S. N., et al. (2018) · Virulence · doi:10.1080/21505594.2018.1475798 · Cited by 21
Potential role of adjuvant drugs on efficacy of first line oral antitubercular therapy: Drug repurposing
Mishra, R., Krishan, S., Siddiqui, A. N., Kapur, P., Khayyam, K. U., & Sharma, M. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.101902 · Cited by 20
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis
Palucci, I., Maulucci, G., Maio, F. D., Sali, M., Romagnoli, A., Petrone, L., Fimia, G. M., Sanguinetti, M., Goletti, D., Spirito, M. D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03042 · Cited by 20
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination
Jayashankar, L., & Hafner, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00577 · Cited by 20
Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia
Alkabab, Y., Enani, M. A., Indarkiri, N. Y., & Heysell, S. K. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s151844 · Cited by 20
Host-directed Therapy: A New Arsenal to Come
Mohan, M., & Bhattacharya, D. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323999200728115857 · Cited by 19
Bioinformatics approach to prioritize known drugs towards repurposing for tuberculosis
Brindha, S., Vincent, S., Velmurugan, D., Ananthakrishnan, D., Sundaramurthi, J. C., & Gnanadoss, J. J. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.04.005 · Cited by 19
DAMP signaling networks: from receptors to diverse pathophysiological functions
Chen, R., Zou, J., Zhong, X. Y., Liu, J., Kang, R., & Tang, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.07.047 · Cited by 26
Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy
Ha, R., Keynan, Y., & Rueda, Z. V. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.980868 · Cited by 18
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
Kumar, N. P., Moideen, K., Nancy, A., Viswanathan, V., Shruthi, B. S., Sivakumar, S., Hissar, S. S., Kornfeld, H., & Babu, S. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4648-1 · Cited by 18
The Association of Premorbid Metformin Exposure With Mortality and Organ Dysfunction in Sepsis: A Systematic Review and Meta-Analysis
Tan, K., Simpson, A., Huang, S., Tang, B. M. P., McLean, A. S., & Nalos, M. (2019) · Critical Care Explorations · doi:10.1097/cce.0000000000000009 · Cited by 17
Persistent dysglycemia is associated with unfavorable treatment outcomes in patients with pulmonary tuberculosis from Peru
Calderon, R. I., Arriaga, M. B., Aliaga, J., Barreda, N. N., Sanabria, O. M., Barreto‐Duarte, B., Franco, J. P. D., Lecca, L. W., Andrade, B. B., Carvalho, A. C. C., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.01.012 · Cited by 20
Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis
Brown, R. E., Hunter, R. L., & Hwang, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00078 · Cited by 17
Analysis of host-pathogen modulators of autophagy during Mycobacterium Tuberculosis infection and therapeutic repercussions
Khan, A., & Jagannath, C. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1356924 · Cited by 17
Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop
Akkina, R., Barber, D. L., Bility, M. T., Bissig, K., Burwitz, B. J., Eichelberg, K., Endsley, J. J., García, J. V., Hafner, R., Karakousis, P. C., et al. (2019) · Current HIV Research · doi:10.2174/1570162x18666191223114019 · Cited by 16
Two Decades of TB Drug Discovery Efforts—What Have We Learned?
Bandodkar, B., Shandil, R. K., Bhat, J. J., & Balganesh, T. S. (2020) · Applied Sciences · doi:10.3390/app10165704 · Cited by 17
The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
Lee, C., & Bhakta, S. (2021) · Antibiotics · doi:10.3390/antibiotics10010091 · Cited by 17
Targeting metabolism for lupus therapy
Mehta, M., & Chandel, N. S. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa6731 · Cited by 17
Small Molecule Targeting PPM1A Activates Autophagy for Mycobacterium tuberculosis Host-Directed Therapy
Yu, Z., Liang, Y. C., Berton, S., Liu, L., Zou, J., Chen, L., Xu, Z., Luo, C., Sun, J., & Yang, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00513 · Cited by 16
Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus
Bravo-Santano, N., Behrends, V., & Letek, M. (2019) · Antibiotics · doi:10.3390/antibiotics8040241 · Cited by 16
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB
Bryk, R., Mundhra, S., Jiang, X., Wood, M., Pfau, D. J., Weber, E., Park, S., Zhang, L., Wilson, C. R., van der Westhuyzen, R., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008567 · Cited by 16
Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
Guo, T., Sun, X., Yang, J., Yang, L., Li, M., Wang, Y., Jiao, H., & Li, G. (2022) · BMC Microbiology · doi:10.1186/s12866-022-02629-4 · Cited by 16
Self-citation
The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy
Shankaran, D., Singh, A., Dawa, S., Arumugam, P., Gandotra, S., & Rao, V. (2023) · eLife · doi:10.7554/elife.64834 · Cited by 14
Role of Oxidative Stress in Tuberculosis Meningitis Infection in Diabetics
Navasardyan, I., Yeganyan, S., Nguyen, H., Vaghashia, P., Subbian, S., & Venketaraman, V. (2023) · Biomedicines · doi:10.3390/biomedicines11092568 · Cited by 15
Host-directed therapy against tuberculosis: Concept and recent developments
Udinia, S., Suar, M., & Kumar, D. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00374-y · Cited by 15
The flavonoids of Sophora flavescens exerts anti-inflammatory activity via promoting autophagy of Bacillus Calmette-Guérin-stimulated macrophages
Kan, L. L., Liu, D., Chan, B. C.-L., Tsang, M. S., Hou, T., Leung, P., Lam, C. W.-K., & Wong, C. K. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0720-682rr · Cited by 16
Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes
Tsai, I., Kuo, C., Lin, A. B., Chien, M.-N., Ho, H., Wei, T., Wu, C., & Lu, Y. (2016) · Respirology · doi:10.1111/resp.12948 · Cited by 16
Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosis
Simwela, N. V., Jaecklein, E., Sassetti, C. M., & Russell, D. G. (2024) · eLife · doi:10.7554/elife.102980.3 · Cited by 25
Metformin has immunomodulatory effects which support its potential use as adjunctive therapy in tuberculosis
Sutter, A., Landis, D. M., & NUGENT, K. M. (2023) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2023.05.011 · Cited by 16
Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
Park, H.-E., Lee, W., Shin, M., & Shin, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703060 · Cited by 16
Identification of Hub Genes Associated with Diabetes Mellitus and Tuberculosis Using Bioinformatic Analysis
Liu, S., Ren, W., Yu, J., Li, C., & Tang, S. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318071 · Cited by 15
The potential role for metformin in the prevention and treatment of tuberculosis
Sutter, A., Landis, D. M., & NUGENT, K. M. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-39 · Cited by 16
Tissue Metabolic Changes Drive Cytokine Responses to Mycobacterium tuberculosis
Lachmandas, E., Rios‐Miguel, A. B., Koeken, V. A. C. M., van der Pasch, E., Kumar, V., Matzaraki, V., Li, Y., Oosting, M., Joosten, L. A. B., Notebaart, R. A., et al. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy173 · Cited by 15
Metabolomics Applied to the Discovery of Tuberculosis and Diabetes Mellitus Biomarkers
Salgado‐Bustamante, M., Rocha‐Viggiano, A. K., Rivas-Santiago, C., Magaña-Aquino, M., López, J. A., & López‐Hernández, Y. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0050 · Cited by 16
B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting α-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases
Kwon, B.-E., Ahn, J.-H., Park, E.-K., Jeong, H., Lee, H.-J., Jung, Y., Shin, S. J., Jeong, H.-S., Yoo, J. S., Shin, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02542 · Cited by 15
Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
Afkhami, S., Villela, A. D., D’Agostino, M. R., Jeyanathan, M., Gillgrass, A. E., & Xing, Z. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.557809 · Cited by 15
Metformin induces iron deprivation and enhances mitochondrial ROS in macrophages creating a hostile environment for survival of intracellular Mycobacterium tuberculosis
Modanwal, R., Chaubey, G. K., Dilawari, R., Talukdar, S., Sindhu, A., Raje, C. I., & Raje, M. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118314 · Cited by 15
Modulating the antibacterial effect of the existing antibiotics along with repurposing drug metformin
Hossain, S., Rafi, R. H., Ripa, F. A., Khan, M. R. I., Hosen, M. E., Molla, M. K. I., Faruqe, M. O., Al‐Bari, M. A. A., & Das, S. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03917-5 · Cited by 14
The development and validation of a LC-MS/MS method for the quantitation of metformin, rifampicin and isoniazid in rat plasma using HILIC chromatography
Govender, K., Adamson, J., & Owira, P. M. O. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.07.041 · Cited by 15
Metformin promotes susceptibility to experimental Leishmania braziliensis infection
Lima, F. R., Ferreira, L. D. M., Malta, T. A., Bonyek-Silva, Í., Santos, R. L., Tavares, N. M., Filho, E. M. D. C., & Arruda, S. M. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200272 · Cited by 14
Fine-tuning of macrophage activation using synthetic rocaglate derivatives
Bhattacharya, B., Chatterjee, S., Devine, W. G., Kobzik, L., Beeler, A. B., Porco, J. A. J., & Kramnik, I. (2016) · Scientific Reports · doi:10.1038/srep24409 · Cited by 14
Hyperglycaemia is inversely correlated with live M. bovis BCG‐specific CD4+ T cell responses in Tanzanian adults with latent or active tuberculosis
Boillat‐Blanco, N., Tumbo, A., Perreau, M., Amelio, P., Ramaiya, K. L., Mganga, M., Schindler, C., Gagneux, S., Reither, K., Probst-Hensch, N. M., et al. (2018) · Immunity Inflammation and Disease · doi:10.1002/iid3.222 · Cited by 13
Host-Directed Therapies and Anti-Virulence Compounds to Address Anti-Microbial Resistant Tuberculosis Infection
Gries, R., Sala, C., & Rybniker, J. (2020) · Applied Sciences · doi:10.3390/app10082688 · Cited by 14
Situación de la comorbilidad tuberculosis y diabetes en personas adultas en el Perú, 2016-2018
Ugarte‐Gil, C., Curisinche-Rojas, M., Herrera-Flores, E. H., Hernandez, H. A. A., & Ríos, J. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.382.6764 · Cited by 14
Autophagy in mycobacterial infections: molecular mechanisms, host-pathogen interactions, and therapeutic opportunities
Li, J., Feng, H., Chen, D., Zhang, H., & Liao, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1640647 · Cited by 14
Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment
Kornfeld, H., Procter-Gray, E., Kumpatla, S., Kane, K., Li, W., Magee, M. J., Babu, S., & Viswanathan, V. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110242 · Cited by 15
Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection
Nagdev, P. K., Agnivesh, P. K., Roy, A., Sau, S., & Kalia, N. P. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04663-0 · Cited by 13
Effect of Metformin on Plasma Exposure of Rifampicin, Isoniazid, and Pyrazinamide in Patients on Treatment for Pulmonary Tuberculosis
Hemanthkumar, A. K., Kadam, A. V., Karunaianantham, R., Manoharan, T., Padmapriyadarsini, C., Mohan, A., Jeyadeepa, B., Radhakrishnan, A., Singh, U. B., Bapat, S. S., et al. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001149 · Cited by 13
Self-citation
Metformin improves Mycobacterium avium infection by strengthening macrophage antimicrobial functions
Mediaas, S. D., Haug, M., Louet, C., Wahl, S. G. F., Gidon, A., & Flo, T. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1463224 · Cited by 13
Cyclic Peptide [R4W4] in Improving the Ability of First-Line Antibiotics to Inhibit Mycobacterium tuberculosis Inside in vitro Human Granulomas
Hernandez, J., Ashley, D., Cao, R., Abrahem, R., Nguyen, T. K., To, K., Yegiazaryan, A., Akinwale, A. D., Tiwari, R. K., & Venketaraman, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01677 · Cited by 13
Chemical p38 MAP kinase inhibition constrains tissue inflammation and improves antibiotic activity in Mycobacterium tuberculosis-infected mice
Hölscher, C., Gräb, J., Hölscher, A., Müller, A., Schäfer, S. C., & Rybniker, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-70184-x · Cited by 13
Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages
Zhang, H., Lu, Q., Zhang, J., Qu, W., Xie, S., Huang, L., Yuan, Z., & Pan, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113657 · Cited by 13
Clinical Characteristics and Prognostic Analysis of Patients With Pulmonary Tuberculosis and Type 2 Diabetes Comorbidity in China: A Retrospective Analysis
Zhang, S., Tong, X., Wang, L., Zhang, T., Huang, J., Wang, D., Wang, L., & Fan, H. S. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.710981 · Cited by 13
Multi-target drugs to address multiple checkpoints in complex inflammatory pathologies: evolutionary cues for novel “first-in-class” anti-inflammatory drug candidates: a reviewer’s perspective
Mathew, G., & Unnikrishnan, M. K. (2015) · Inflammation Research · doi:10.1007/s00011-015-0851-8 · Cited by 13
Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious Diseases
Mahon, R. N., & Hafner, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00688 · Cited by 13
Association between IL-15 and insulin plasmatic concentrations in patients with pulmonary tuberculosis and type 2 diabetes
Sánchez-Jiménez, R., Cerón, E., Bernal-Alcántara, D. A., Castillejos-López, M. D. J., González-Trujano, E., Negrete-García, M. C., & Alvarado‐Vásquez, N. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.06.009 · Cited by 13
Current and emerging therapies to combat persistent intracellular pathogens
Arandjelovic, P., Doerflinger, M., & Pellegrini, M. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.013 · Cited by 14
Combining bioinformatics and biological detection to identify novel biomarkers for diagnosis and prognosis of pulmonary tuberculosis
Zhao, G., Luo, X., Han, X., & Liu, Z. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.4.24989 · Cited by 13
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages
van Doorn, C. L. R., Steenbergen, S. A. M., Walburg, K. V., & Ottenhoff, T. H. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712021 · Cited by 12

Authors: Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., Kreiswirth, B., Poidinger, M., Chee, C., Kaplan, G., Wang, Y. T., & De Libero, G.
Affiliations: Agency for Science, Technology and Research (SG)
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
Tan Tock Seng Hospital (SG)
Rutgers, The State University of New Jersey (US)
Corresponding author: Singhal, Amit
Kumar, Pavanish
ORCID: Singhal, Amit
Kumar, Pavanish
Leow, Melvin Khee-Shing
Paleja, Bhairav
Chen, Jinmiao
Zolezzi, Francesca
Kreiswirth, Barry
Poidinger, Michael
Chee, Cynthia
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2014-11-19
Volume: 6
Issue: 263
Pages: 263ra159-263ra159
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3009885
OpenAlex: W2105296171
Cited by: 547
References: 49
Citations by year: 2026: 39 · 2025: 44 · 2024: 44 · 2023: 35 · 2022: 51 · 2021: 64 · 2020: 71 · 2019: 53 · 2018: 51 · 2017: 33 · 2016: 35 · 2015: 24 · 2014: 2
FWCI: 22.03
Type: journal article
Language: en
Open access: closed
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
edoc (University of Basel) (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: metformin, tuberculosis, Mycobacterium tuberculosis, AMPK, host-directed therapy, drug-resistant tuberculosis, reactive oxygen species, phagosome-lysosome fusion, host immune response, chronic inflammation
MeSH terms: Humans, Metformin, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Tuberculosis, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin as adjunct antituberculosis therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks